15 Nov
|
Iovance
|
Sydney
Iovance Biotherapeutics, Inc. is seeking a Commercial Lead for Australia to establish and scale the company's TIL therapies in the Australian market.
You will own the commercial strategy, P&L;, forecasts and market development for AMTAGVI and Proleukin, from launch through expansion. Reporting to the SVP Global Access, Operations and Proleukin, you will build a country organisation, lead treatment-centre activation, manage budgets, and partner with healthcare authorities and centres to ensure
#J-18808-Ljbffr
📌 Australia Commercial Lead – TIL Therapy Launch (Sydney)
🏢 Iovance
📍 Sydney